Not for distribution in the U.S. or to U.S. Newswires
VANCOUVER, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B), (“Blissco”) or the (“Company”) is a Canadian wellness cannabis brand based in British Columbia and licensed processor, cultivator and distributor of premium dried cannabis and cannabis oil. Today, the company is pleased to announce that it has earned Depository Trust Company (DTC) eligibility, which means that Blissco stock is now more accessible to U.S. investors.
The DTC is the largest securities deposit in the world and it will facilitate electronic settlement of transfers of Blissco common shares in the United States. Securities that are eligible to be electronically cleared and settled through the DTC are considered "DTC eligible”.
“We are very excited to be DTC eligible; which opens up a tremendous opportunity for U.S. investors to participate in our growth,” said Damian Kettlewell, Blissco CEO. “Blissco is truly beginning to make its mark in domestic and international markets by expanding our global investor base.”
This electronic method of clearing securities speeds up the receipt of stock and cash, and thus accelerates the settlement process for investors and brokers. Companies that are DTC eligible often experience higher trading volumes in their stock given the additional accessibility and availability of shares for trading.
About Blissco Cannabis Corp. Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B) is a Canadian wellness cannabis brand based in British Columbia and a multi-licensed processor, cultivator and distributor of premium cannabis.
Blissco owns and operates a state-of-the-art GPP facility located in Metro Vancouver, British Columbia with 18,000 square feet of extraction, cultivation and processing rooms. Blissco is supplying premium cannabis and small-batch Reserve whole flower and pre-rolls to the Canadian and global marketplace with a growing list of provincial cannabis boards and international distribution partners.
With a license to process cannabis oil acquired in August 2018, Blissco’s extraction lab is also in operation preparing a line of full spectrum oils for distribution in 2019. Learn more: Blissco.com On Behalf of the Board of Directors BLISSCO CANNABIS CORP. Damian Kettlewell, CEO, Founder & Chair For further information please contact: 1 604 484-9119 investors@blissco.com Cautionary Statements This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the ability to execute on our strategic plans and the impact on our future operations, capital expenditures, receipt of a cannabis oil license and a license to sell dried cannabis and other objectives. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law. The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.
